# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA289093 | Butoxamine | Selectivity ratio | = | 2 | ALA3280060 | Cavia porcellus | |||||
2. | ALA289093 | Butoxamine | Selectivity ratio | = | 13 | ALA3280059 | ||||||
3. | ALA289093 | Butoxamine | pIC50 | < | 4.7 | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | |||
4. | ALA289093 | Butoxamine | IC50 | > | 0 | M | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | ||
5. | ALA289093 | Butoxamine | Selectivity index | = | 346 | ALA880540 | ||||||
6. | ALA289093 | Butoxamine | pA10 | = | 5.96 | ALA651629 | Cavia porcellus | |||||
7. | ALA289093 | Butoxamine | pA2 | = | 6.89 | ALA651630 | 6.89 | nM | Cavia porcellus | |||
8. | ALA289093 | Butoxamine | pA10 | = | 3.98 | ALA877267 | Cavia porcellus | |||||
9. | ALA289093 | Butoxamine | pA2 | = | 4.35 | ALA653375 | 4.35 | nM | Cavia porcellus | |||
10. | ALA289093 | Butoxamine | T/A | = | 347 | ALA840749 | Homo sapiens | |||||
11. | ALA289093 | Butoxamine | pA2 - pA10 | = | 0.93 | ALA650092 | Cavia porcellus | |||||
12. | ALA289093 | Butoxamine | pA10 | = | 5.96 | ALA876530 | Cavia porcellus | |||||
13. | ALA289093 | Butoxamine | pA2 | = | 6.89 | ALA651631 | 6.89 | nM | Cavia porcellus | |||
14. | ALA289093 | Butoxamine | pA2 - pA10 | = | 0.37 | ALA650928 | Cavia porcellus | |||||
15. | ALA289093 | Butoxamine | pA10 | = | 3.98 | ALA653374 | Cavia porcellus | |||||
16. | ALA289093 | Butoxamine | pA2 | = | 4.35 | ALA653376 | 4.35 | nM | Cavia porcellus | |||
17. | ALA289093 | Butoxamine | Inhibition | = | 26.8 | % | ALA806153 | % | Homo sapiens | |||
18. | ALA289093 | Butoxamine | IC50 | = | 27 | uM | ALA806152 | 4.57 | nM | Homo sapiens |